EMPLOYMENT AGREEMENTEmployment Agreement • February 22nd, 2024 • Amylyx Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Employment Agreement (“Agreement”) is made between Amylyx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Camille Bedrosian, M.D., 25 Moncada Way, San Rafael, CA, 94901 (the “Executive”).
SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • February 22nd, 2024 • Amylyx Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This SEPARATIONAND RELEASE AGREEMENT (the “Agreement”) is entered into by and among Margaret Olinger, M.B.A. (the “Executive”), and Amylyx Pharmaceuticals, Inc., a Delaware corporation (the “Company”). This Agreement is entered into effective as of December 31, 2023. The Executive and the Company are hereinafter collectively referred to as the “Parties” and each are individually referred to as a “Party”.
2nd AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • February 22nd, 2024 • Amylyx Pharmaceuticals, Inc. • Pharmaceutical preparations
This 2nd Amendment to Employment Agreement (“Amendment”) is made between Amylyx Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Patrick Yeramian, M.D. (“Executive”) and is effective as of November 27, 2023 (the “Effective Date”).
